Two new treatments are proving to be the most effective treatment in decades for some people with bladder cancer, according to groundbreaking trial results in two separate studies.
Researchers found that in both trials, patients who received a combination of immunotherapy drugs lived longer than those who received standard chemotherapy treatment, marking a never-before-seen improvement in treatment for advanced bladder cancer.
The advancements are seen as "monumental" in urology, Dr. Andrea Apolo of the National Cancer Institute's Genitourinary Malignancies Branch said in a press release. "The future looks bright for our patients."
Read Full Article Here
New Treatments Extend Lives of Advanced Bladder Cancer Patients
- by: Amie Dahnke
- 12.04.23
- Source:
The Epoch Times
- 12/05/2023
Microtentacles and Metastasis by National Cancer Institute is licensed under Unsplash unsplash.com
Microtentacles and Metastasis by National Cancer Institute is licensed under Unsplash unsplash.com
Follow us
Read our latest news on any of these social networks!
Get latest news delivered daily!
We will send you breaking news right to your inbox
Have a tip? Let us know!
Recent Articles
- by: Akshay Syal, M.D
- Source:
NBC News
- 05/09/2025
FDA approves at-home HPV test to screen for cervical cancer
Traditional tests are done during a pelvic exam in the doctor’s office, an experience that many women find uncomfortable.
- by: Breitbart London
- Source:
Breitbart
- 05/09/2025
Ukraine Parliament Ratifies Trump’s Rare Earths Mineral Deal
KYIV, Ukraine (AP) – Ukraine’s Parliament unanimously voted in favor of ratifying of a landmark minerals deal with the U.S. on Thursday afternoon, a lawmaker said.
- by: David K. Li
- Source:
NBC News
- 05/09/2025
Luigi Mangione's legal defense fund hits $1 million in donations
Organizers said the financial milestone came from over 28,000 donations, with a median contribution of $20.
- by: Tobias Burns
- Source:
The Hill
- 05/08/2025
Fed holds rates steady despite pressure from Trump
The Federal Reserve’s interest rate setting committee held rates steady Wednesday at a range of 4.25 percent to 4.5 percent, despite calls from President Trump to lower borrowing costs amid price pressures from his trade war.